Solid Lipid Nanoparticles (SLNs): An Advanced Drug Delivery System Targeting Brain through BBB
The blood–brain barrier (BBB) plays a vital role in the protection and maintenance of homeostasis in the brain. In this way, it is an interesting target as an interface for various types of drug delivery, specifically in the context of the treatment of several neuropathological conditions where the...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-07-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/13/8/1183 |
| _version_ | 1797522453817196544 |
|---|---|
| author | Mantosh Kumar Satapathy Ting-Lin Yen Jing-Shiun Jan Ruei-Dun Tang Jia-Yi Wang Rajeev Taliyan Chih-Hao Yang |
| author_facet | Mantosh Kumar Satapathy Ting-Lin Yen Jing-Shiun Jan Ruei-Dun Tang Jia-Yi Wang Rajeev Taliyan Chih-Hao Yang |
| author_sort | Mantosh Kumar Satapathy |
| collection | DOAJ |
| description | The blood–brain barrier (BBB) plays a vital role in the protection and maintenance of homeostasis in the brain. In this way, it is an interesting target as an interface for various types of drug delivery, specifically in the context of the treatment of several neuropathological conditions where the therapeutic agents cannot cross the BBB. Drug toxicity and on-target specificity are among some of the limitations associated with current neurotherapeutics. In recent years, advances in nanodrug delivery have enabled the carrier system containing the active therapeutic drug to target the signaling pathways and pathophysiology that are closely linked to central nervous system (CNS) disorders such as Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), multiple sclerosis (MS), brain tumor, epilepsy, ischemic stroke, and neurodegeneration. At present, among the nano formulations, solid lipid nanoparticles (SLNs) have emerged as a putative drug carrier system that can deliver the active therapeutics (drug-loaded SLNs) across the BBB at the target site of the brain, offering a novel approach with controlled drug delivery, longer circulation time, target specificity, and higher efficacy, and more importantly, reducing toxicity in a biomimetic way. This paper highlights the synthesis and application of SLNs as a novel nontoxic formulation strategy to carry CNS drugs across the BBB to improve the use of therapeutics agents in treating major neurological disorders in future clinics. |
| first_indexed | 2024-03-10T08:29:37Z |
| format | Article |
| id | doaj.art-cdec0a22ed0044098e7243a37535a271 |
| institution | Directory Open Access Journal |
| issn | 1999-4923 |
| language | English |
| last_indexed | 2024-03-10T08:29:37Z |
| publishDate | 2021-07-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Pharmaceutics |
| spelling | doaj.art-cdec0a22ed0044098e7243a37535a2712023-11-22T09:13:54ZengMDPI AGPharmaceutics1999-49232021-07-01138118310.3390/pharmaceutics13081183Solid Lipid Nanoparticles (SLNs): An Advanced Drug Delivery System Targeting Brain through BBBMantosh Kumar Satapathy0Ting-Lin Yen1Jing-Shiun Jan2Ruei-Dun Tang3Jia-Yi Wang4Rajeev Taliyan5Chih-Hao Yang6Department of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, No. 250, Wu Hsing St., Taipei 110, TaiwanDepartment of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, No. 250, Wu Hsing St., Taipei 110, TaiwanDepartment of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, No. 250, Wu Hsing St., Taipei 110, TaiwanDepartment of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, No. 250, Wu Hsing St., Taipei 110, TaiwanGraduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, No. 250, Wu Hsing St., Taipei 110, TaiwanDepartment of Pharmacy, Neuropsychopharmacology Division, Birla Institute of Technology and Science, Pilani 333031, IndiaDepartment of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, No. 250, Wu Hsing St., Taipei 110, TaiwanThe blood–brain barrier (BBB) plays a vital role in the protection and maintenance of homeostasis in the brain. In this way, it is an interesting target as an interface for various types of drug delivery, specifically in the context of the treatment of several neuropathological conditions where the therapeutic agents cannot cross the BBB. Drug toxicity and on-target specificity are among some of the limitations associated with current neurotherapeutics. In recent years, advances in nanodrug delivery have enabled the carrier system containing the active therapeutic drug to target the signaling pathways and pathophysiology that are closely linked to central nervous system (CNS) disorders such as Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), multiple sclerosis (MS), brain tumor, epilepsy, ischemic stroke, and neurodegeneration. At present, among the nano formulations, solid lipid nanoparticles (SLNs) have emerged as a putative drug carrier system that can deliver the active therapeutics (drug-loaded SLNs) across the BBB at the target site of the brain, offering a novel approach with controlled drug delivery, longer circulation time, target specificity, and higher efficacy, and more importantly, reducing toxicity in a biomimetic way. This paper highlights the synthesis and application of SLNs as a novel nontoxic formulation strategy to carry CNS drugs across the BBB to improve the use of therapeutics agents in treating major neurological disorders in future clinics.https://www.mdpi.com/1999-4923/13/8/1183neurological disordersBBBnano drug deliverySLN |
| spellingShingle | Mantosh Kumar Satapathy Ting-Lin Yen Jing-Shiun Jan Ruei-Dun Tang Jia-Yi Wang Rajeev Taliyan Chih-Hao Yang Solid Lipid Nanoparticles (SLNs): An Advanced Drug Delivery System Targeting Brain through BBB Pharmaceutics neurological disorders BBB nano drug delivery SLN |
| title | Solid Lipid Nanoparticles (SLNs): An Advanced Drug Delivery System Targeting Brain through BBB |
| title_full | Solid Lipid Nanoparticles (SLNs): An Advanced Drug Delivery System Targeting Brain through BBB |
| title_fullStr | Solid Lipid Nanoparticles (SLNs): An Advanced Drug Delivery System Targeting Brain through BBB |
| title_full_unstemmed | Solid Lipid Nanoparticles (SLNs): An Advanced Drug Delivery System Targeting Brain through BBB |
| title_short | Solid Lipid Nanoparticles (SLNs): An Advanced Drug Delivery System Targeting Brain through BBB |
| title_sort | solid lipid nanoparticles slns an advanced drug delivery system targeting brain through bbb |
| topic | neurological disorders BBB nano drug delivery SLN |
| url | https://www.mdpi.com/1999-4923/13/8/1183 |
| work_keys_str_mv | AT mantoshkumarsatapathy solidlipidnanoparticlesslnsanadvanceddrugdeliverysystemtargetingbrainthroughbbb AT tinglinyen solidlipidnanoparticlesslnsanadvanceddrugdeliverysystemtargetingbrainthroughbbb AT jingshiunjan solidlipidnanoparticlesslnsanadvanceddrugdeliverysystemtargetingbrainthroughbbb AT rueiduntang solidlipidnanoparticlesslnsanadvanceddrugdeliverysystemtargetingbrainthroughbbb AT jiayiwang solidlipidnanoparticlesslnsanadvanceddrugdeliverysystemtargetingbrainthroughbbb AT rajeevtaliyan solidlipidnanoparticlesslnsanadvanceddrugdeliverysystemtargetingbrainthroughbbb AT chihhaoyang solidlipidnanoparticlesslnsanadvanceddrugdeliverysystemtargetingbrainthroughbbb |